Comparative study between patients who received risedronate GR with those treated with immediate release bisphosphonates: An observational retrospective study
Latest Information Update: 28 Apr 2021
Price :
$35 *
At a glance
- Drugs Risedronic acid (Primary) ; Bisphosphonates
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2021 Drug route and form assumed.
- 28 Apr 2021 New trial record
- 26 Apr 2021 According to a Theramex media release, data from the study resented at the 13th International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders.